Clinical trial

Safety and Efficacy Study of Bimatoprost in Patients With Glaucoma or Ocular…

NCT00300443 · Allergan, Industry · Completed

Key facts

NCT number NCT00300443
Title Safety and Efficacy Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension
Lead sponsor Allergan, Industry
Status Completed
Phase Phase 2/Phase 3
Study type Interventional
Conditions Ocular Hypertension
Intervention type Drug
Interventions bimatoprost
Enrollment 561
Start date Dec 1, 2005
Primary completion Jun 1, 2007
Completion Jun 1, 2007
First posted Mar 9, 2006
Last update posted May 30, 2011
Countries United States

At a glance

  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies